Disclosure Of Entity's Operating Segments [Text Block]

Transgene - Filing #2813436

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	NOTE 23	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)	—	—	—	—	—	—	- EUR	—	—	—	—	—	—	—	—	—	—	- EUR
Profit (loss) before tax	—	—	—	—	—	—	32 804 EUR	—	—	—	—	—	—	—	—	—	—	19 536 EUR
Profit (loss)	—	- EUR	32 804 EUR	- EUR	32 804 EUR	- EUR	32 804 EUR	- EUR	- EUR	—	- EUR	- EUR	- EUR	19 536 EUR	- EUR	- EUR	19 536 EUR	19 536 EUR
Assets	66 436 EUR	—	—	—	—	—	—	—	—	101 838 EUR	—	—	—	—	—	—	—	—
Liabilities	28 595 EUR	—	—	—	—	—	—	—	—	34 629 EUR	—	—	—	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	—	—	20 303 EUR	—	—	—	—	—	—	—	—	—	—	25 909 EUR
Cash flows from (used in) investing activities	—	—	—	—	—	—	20 272 EUR	—	—	—	—	—	—	—	—	—	—	5 789 EUR
Cash flows from (used in) financing activities	—	—	—	—	—	—	1 477 EUR	—	—	—	—	—	—	—	—	—	—	32 320 EUR